miércoles, 2 de enero de 2008

Lo mejor de Journal Watch 2007

General Medicine for January 1, 2008

Top Medical Stories of 2007
Letter to Readers Free
. . . as chosen by the editors of Journal Watch.
By Allan S. Brett, MD, Editor-in-Chief
December 28, 2007

Medical vs. Invasive Approaches in Patients with Stable Angina
Although patients benefited similarly from both approaches in a randomized trial, cardiologists believe that PCI is better.
By Kirsten E. Fleischmann, MD, MPH
December 28, 2007

Surgery or Watchful Waiting for Lumbar Disk Herniation?
Long-term results are comparable, so patient choice plays a big role.
By Thomas L. Schwenk, MD
December 28, 2007

Rosiglitazone: Unclear Evidence, Uncertain Practice
Does rosiglitazone significantly increase risk for cardiovascular death or MI? It depends on how the data are analyzed . . .
By Richard Saitz, MD, MPH, FACP, FASAM
December 28, 2007

Effects of Inhaled Therapy on Mortality in COPD
Active therapies didn't lower 3-year mortality significantly, but some outcomes were better with combined therapy or long-acting β-agonist monotherapy than with steroid monotherapy.
By Allan S. Brett, MD
December 28, 2007

New Guidelines for Prevention of Endocarditis
Now that the AHA has updated its guidelines, many fewer patients should receive antibiotic courses before routine procedures.
By Allan S. Brett, MD
December 28, 2007

Benefits and Risks of Long-Term Alendronate
The FLEX study results help us determine for whom long-term alendronate therapy is beneficial.
By Anthony L. Komaroff, MD
December 28, 2007

A Bad Year for Pharmaceutical Erythropoietins
Epoetins are valuable agents but should be used sparingly.
By Paul S. Mueller, MD, MPH, FACP
December 28, 2007

Dietary Supplements Don’t Prevent Cognitive Decline, CVD, or Infections
Top Story Free
Several studies and a meta-analysis all led to the same conclusion — no benefit from supplementation.
By Jamaluddin Moloo, MD, MPH
December 28, 2007

Potpourri of Pediatric Research: 2007
Top Story Free
Three interventions yielded no benefit; a fourth is a success story.
December 28, 2007

Human Stem-Cell Breakthrough
Top Story Free
Adult human cells finally have been manipulated into becoming fully pluripotent human ESCs.
By Anthony L. Komaroff, MD
December 28, 2007

Allan S. Brett, MD, Editor-in-Chief
Published in Journal Watch General Medicine December 28, 2007